What's new? Log in Free sign up

Filing search / Aerovate Therapeutics, Inc. / "Women"

Search information

Aerovate Therapeutics, Inc.

Companies

"Women"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

7 results

Newest first Best match first

AVTE Aerovate Therapeutics, Inc.

diagnosed is between 30,000 and 40,000 in the United States with an average age at diagnosis of 53 years old and 65% to 80% of those diagnosed being women

25 Mar 24

4:15pm

AVTE Aerovate Therapeutics, Inc.

in the United States with an average age at diagnosis of 53 years old and 65% to 80% of those diagnosed being women. The exact prevalence of PAH worldwide

29 Mar 23

5:04pm

AVTE Aerovate Therapeutics, Inc.

with an average age at diagnosis of 53 years old and 65% to 80% of those diagnosed being women. The exact prevalence of PAH worldwide is not known but it has been

AVTE Aerovate Therapeutics, Inc.

Prospectus supplement with pricing info

with an average age at diagnosis of 53 years old and 65% to 80% of those diagnosed being women. The exact prevalence of PAH worldwide is not known but it has been

AVTE Aerovate Therapeutics, Inc.

IPO registration (amended)

is between 30,000 and 40,000 in the United States with an average age at diagnosis of 53 years old and 65% to 80% of those diagnosed being women. The exact

24 Jun 21

6:03am

IPO registration

Draft registration statement

Prev
1
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.